source
- Supreme Court Declines to Hear Lawsuits Against Medicare Drug Price Negotiation ProgramThe U.S. Supreme Court on Monday refused to hear challenges to the Medicare drug price negotiation program, delivering a setback to the pharmaceutical industry's legal effort. The Court declined t…
- US biotech faces internal split over reliance on Chinese-developed drug candidatesEd Silverman's Pharmalittle column notes that US biotech firms are wrestling with how to treat Chinese partners, with some seeing them as collaborators and others as competitors. The column highli…